SPY305.97+0.42 0.14%
DIA256.41+1.14 0.45%
IXIC9,504.16-47.89 -0.50%

CFRA Upgrades Medtronic to Strong Buy, Lowers Price Target of $121

CFRA upgrades Medtronic (NYSE:MDT) from Buy to Strong Buy and lowers the price target from $127 to $121.

Benzinga · 05/21/2020 17:08

CFRA upgrades Medtronic (NYSE:MDT) from Buy to Strong Buy and lowers the price target from $127 to $121.